← Back to Clinical Trials
Recruiting NCT06990048
The Long-Term EVAR Assessment and Follow-Up (LEAF) Study for the AFX2 System
Trial Parameters
Condition Abdominal Aortic Aneurysm
Sponsor Endologix
Study Type OBSERVATIONAL
Phase N/A
Enrollment 2,000
Sex ALL
Min Age N/A
Max Age N/A
Start Date 2023-09-21
Completion 2027-05
Interventions
AFX2 System
Brief Summary
This is an observational, retrospective, multicenter study to evaluate the performance of the AFX2 System using real world evidence from VQI-VISION.
Eligibility Criteria
Inclusion Criteria: * All patients implanted with the AFX2 System or the 3 most commonly used comparator devices who underwent EVAR as their first abdominal aortic aneurysm repair in the VQI EVAR registry will be included in this study. Exclusion Criteria: * Ruptured AAA repair with the AFX2 or comparator device * Patients with AFX2 in AFX relining, or relined comparator grafts.
Related Trials
NCT04746677
Safety and Efficacy of Endovascular Repair of Complex Aortic Pathology With Physician-modified Endov
View Trial →
NCT06969729
Evaluation of Clinical Efficacy and Safety of Aortal Stent-Graft Created Using 3D Printing Technolog
View Trial →
NCT05665101
EndoVascular Aortic Repair With Sac Embolization for the Prevention of Type II Endoleaks (the EVAR-S
View Trial →